Claims

ChatGPT-4 outperformed ChatGPT-3.5 in every postgraduate examination both models were tested on

Claim · All claims
Evidence · 1 study · review r2 · q2
Currency · newest study 2024 · not yet checked against its sources · not reviewed by a person · recheck by 2027: tool and model accuracy changes quickly

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? ChatGPT-4 outperformed ChatGPT-3.5 in all examinations taken by both models, with the difference reported as statistically significant in four examinations including MRCP Part 1 (P<0.001). → Vij O 2024

Evidence

Vij O 2024

Vij O, Calver H, Myall N, Dey M, Kouranloo K. (2024). Evaluating the competency of ChatGPT in MRCP Part 1 and a systematic literature review of its capabilities in postgraduate medical assessments. PLOS ONE. https://doi.org/10.1371/journal.pone.0307372

q2 · i? · review · r2

Combined analysis drawing on the included studies and this study's MRCP result; the article reports the ChatGPT-4 advantage was "significantly greater in four examinations, including MRCP Part 1 (P<0.001)".

"ChatGPT-4 outperformed ChatGPT-3.5 in all examinations that were taken by both LLMs. This was reported to be significantly greater in four examinations, including MRCP Part 1 (P<0.001) [37,42,43]."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-31
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.